Martin Nabwana
Overview
Explore the profile of Martin Nabwana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wannume H, Niyonzima N, Kalungi S, Okuni J, Okecha T, Kakungulu E, et al.
PLoS One
. 2025 Jan;
20(1):e0311185.
PMID: 39752420
The detection of Estrogen Receptor (ER), Progesterone Receptor (PR), and Human epidermal growth factor receptor 2 (HER-2) is important for the stratification of breast cancer and the selection of therapeutic...
2.
Mulindwa F, Schwarz J, Brusselaers N, Nabwana M, Bollinger R, Buzibye A, et al.
BMC Infect Dis
. 2024 Jul;
24(1):746.
PMID: 39075383
Background: The Uganda ministry of Health recommends frequent blood glucose monitoring for the first six months on dolutegravir, in people with HIV (PWH) having pre-diabetes mellitus (pre-DM). We sought to...
3.
Okello C, Shih A, Nabwana M, Kiwanuka N, Heddle N, Mayanja-Kizza H, et al.
Afr Health Sci
. 2024 Jul;
23(4):362-370.
PMID: 38974296
Background: There is limited data on red blood cell (RBC) alloimmunization in patients with cancer in sub-Saharan Africa (SSA). We examined the frequency of RBC alloimmunization in transfused patients with...
4.
Okello C, Orem J, Nabwana M, Kiwanuka N, Shih A, Heddle N, et al.
BMC Cancer
. 2024 Jun;
24(1):677.
PMID: 38831291
Background: Mortality benefit of transfusion with leucoreduced whole blood has not been demonstrated in the sub-Saharan Africa (SSA). We compared mortality in patients with cancer transfused with leucoreduced and non-leucoreduced...
5.
Baluku J, Namiiro S, Namanda B, Nabwana M, Andia-Biraro I, Worodria W, et al.
Dis Markers
. 2024 Jan;
2024:8822024.
PMID: 38292339
Objective: The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) demonstrate good diagnostic accuracy in distinguishing lung cancer patients from healthy individuals, primarily in HIV-negative populations. We determined the sensitivity (Se),...
6.
Mulindwa F, Castelnuovo B, Brusselaers N, Nabwana M, Bollinger R, Buzibye A, et al.
AIDS Res Ther
. 2023 Sep;
20(1):65.
PMID: 37689695
Background: The Uganda Ministry of Health issued restrictive guidelines on the use of dolutegravir (DTG) in persons stratified to have a heightened risk of diabetes mellitus. This followed multiple reports...
7.
Mulindwa F, Schwarz J, Brusselaers N, Nabwana M, Bollinger R, Buzibye A, et al.
Res Sq
. 2023 Aug;
PMID: 37577475
Background: The Uganda ministry of Health recommends frequent blood glucose monitoring for the first six months on dolutegravir, in people with HIV (PWH) having pre-diabetes mellitus (pre-DM). We sought to...
8.
Mulindwa F, Castelnuovo B, Brusselaers N, Nabwana M, Bollinger R, Laker E, et al.
Res Sq
. 2023 Jul;
PMID: 37502917
Background The Uganda Ministry of Health issued restrictive guidelines on the use of dolutegravir (DTG) in persons stratified to have a heightened risk of diabetes mellitus. This followed multiple reports...
9.
Baluku J, Namiiro S, Namanda B, Katusabe S, Namusoke D, Nkonge R, et al.
Mutat Res Genet Toxicol Environ Mutagen
. 2023 May;
888:503640.
PMID: 37188437
Objective: To compare cytogenetic abnormalities among people living with HIV (PLWH) with and without previous exposure to Mycobacterium tuberculosis (Mtb) (both latent tuberculosis infection [LTBI] and active tuberculosis [TB]). Methods:...
10.
Mulindwa F, Castelnuovo B, Brusselaers N, Bollinger R, Rhein J, Edrisa M, et al.
AIDS Res Ther
. 2023 Mar;
20(1):15.
PMID: 36915103
Background: Following reports of anti-retroviral therapy (ART) experienced Ugandan people living with HIV (PLHIV) presenting with diabetic ketoacidosis weeks to months following a switch to dolutegravir (DTG), the Uganda Ministry...